SMR

NuScale Power is exploring industrial heat applications for its small modular reactors, with a 12-module plant potentially delivering 3 gigawatts of thermal energy and cutting chemical plant CO2 emissions by 80%-90%. The company is developing steam compression technology to expand industrial applications.

However, commercial adoption remains uncertain as NuScale must demonstrate systems at scale, secure customers, and arrange financing. Other nuclear developers like NANO Nuclear Energy and Oklo are pursuing similar strategies.

NuScale Power stock has plunged over 90% from its $57 peak despite growing demand for nuclear energy in data centers. The company's outlook could be transformed by a potential binding deal with the Tennessee Valley Authority for up to 6 GW of power deployment, which would require up to 72 NuScale Power Modules. Until such a firm commitment materializes, NuScale remains a risky, story-driven stock with significant downside risk.

NuScale Power's stock has plummeted 85% from its $53 peak to under $8, driven by investor sentiment swings rather than business fundamentals. The company, which develops small modular nuclear reactors (SMRs), has an approved design but hasn't secured its first commercial customer yet. A signed contract with RoPower or participation in major U.S. nuclear deployment programs could be the catalyst to push the stock toward $20, though the company remains a high-risk startup with significant execution risks ahead.

The article analyzes four nuclear reactor stocks and their potential valuations by 2031. Oklo, NuScale Power, and Nano Nuclear Energy face significant execution risks with current stock prices appearing to price in substantial post-2031 growth. BWX Technologies, a more established supplier with existing revenue, carries less commercialization risk but trades at a premium valuation with limited upside room.

NuScale Power stock fell 14.8% in September and nearly 55% year-to-date amid analyst downgrades, cash-burn concerns, and competitive pressure. UBS downgraded the stock to sell with a $6 price target, citing lack of firm customer commitments and a 5+ year build timeline while competitors advance faster.

The company reported a 99% revenue collapse to $75,000 in Q2 with $65 million in operational losses. Investors await Q3 earnings on Nov. 5 for news on converting the non-binding TVA agreement into a definite contract.

Three publicly traded small modular reactor (SMR) companies are positioned to benefit from AI data center power demands. Oklo has the largest backlog (18.1 GW) but much is nonbinding; NuScale offers traditional utility-focused approach with 6-7 GW backlog concentrated with one customer; GE Vernova has the highest quality backlog with active construction projects but weakest SMR exposure at under 3% of sales.

Wall Street firms predict a nuclear energy renaissance driven by AI data center demand, which is expected to increase power consumption by 175% by 2030. Investors can gain exposure through three approaches: small modular reactor (SMR) developers like NuScale and Oklo, nuclear utility operators like Constellation Energy, or uranium ETFs.

Amazon announced a 20-year nuclear power deal with Constellation Energy, investing $3 billion to expand an existing nuclear facility. This demonstrates that major AI companies are willing to work through traditional utility operators to scale regional power production, which is positive news for NuScale Power, a small modular reactor company targeting utility companies.

X-Energy, a small modular reactor (SMR) developer, went public at $23 per share in April 2026 but has since dropped to $14, trading 40% below its IPO price. While the company has secured major deals with Amazon and Dow, it faces significant challenges including unproven TRISO fuel technology, regulatory hurdles with the NRC, and a premium valuation at 19x sales despite ongoing losses. The analyst recommends avoiding X-Energy in favor of more established nuclear players like BWX Technologies.

NuScale Power, a small modular reactor developer, has seen its stock fall 45% in 2026 despite analyst optimism. With a median price target of $11 (40.5% upside from $7.83), a $1,000 investment could reach ~$1,405 by September 2027.

However, the wide analyst range ($6-$20 targets) reflects significant uncertainty, as NuScale has no commercial operations and won't deploy reactors until 2030. The stock suits only aggressive, speculative investors or those diversifying across multiple nuclear energy companies.

The global Small Modular Reactor (SMR) market is expected to expand at a 4.93% CAGR through 2031, driven by decarbonization goals, major tech company investments in nuclear power, and government funding initiatives. However, the lack of harmonized international licensing frameworks remains a significant obstacle to market growth. Key trends include repurposing retired coal infrastructure and expanding SMR applications to industrial process heat.

NuScale Power's stock has experienced extreme volatility, trading from $52 to $2 over three years and currently around $8.75. The company develops small modular nuclear reactors (SMRs) but has yet to secure its first commercial sale, though it has potential deals in discussion with RoPower, ENTRA1 Energy, and the Tennessee Valley Authority. The article cautions that NuScale is a high-risk, money-losing startup in a capital-intensive, heavily regulated industry with limited track record, making it suitable only for aggressive investors.

Centrus Energy is positioned as an attractive nuclear investment opportunity due to its dominant position as the only HALEU enricher in the Western World. With a $4.5 billion backlog of LEU and HALEU sales commitments and a $2.4 billion market cap, the company could potentially grow tenfold as advanced reactor makers scale operations, offering significant wealth-building potential without needing to build reactors itself.

Oklo Inc. (OKLO) achieved first criticality at its Groves-1 Isotope Test Reactor in Texas in August 2026, following DOE startup authorization in July. The facility completed substantial construction in 229 days and secured enriched ytterbium-176 for cancer-treatment isotope production.

The company plans to leverage this experience for future isotope facilities while its Idaho lab may generate earlier revenues. However, OKLO shares have declined over 80% in the past year and carry a Zacks Rank #4 (Sell) rating.

The nuclear power sector is experiencing a renaissance driven by AI and electric vehicle demand. While high-risk upstarts like Oklo and NuScale offer cutting-edge technology, they are unprofitable with minimal revenue. Safer alternatives include dividend stocks: Constellation Energy (high growth, low yield), NextEra Energy (balanced growth and income), and Brookfield Renewable (high yield with diversified clean energy assets).

Oklo is developing small sodium-cooled nuclear reactors aimed at providing clean, around-the-clock power. While the company has a talented leadership team and agreements with AI infrastructure companies, a preprint study suggests small modular reactors face significant profitability challenges due to high operating costs that could offset savings from cheaper construction. The article concludes Oklo remains highly speculative with no guarantee of success.

Oklo Inc. (OKLO) shares have declined 76.5% over the past year as investors grow concerned about mounting near-term execution risks, widening losses, and rising capital requirements. The company increased its 2026 operating cash-use forecast to $120M-$150M and capital spending to $400M-$500M, while its first commercial Aurora powerhouse targets 2028. Despite a substantial $3 billion cash position and progress in fuel and isotope projects, regulatory hurdles, commercialization delays, and shareholder dilution remain significant risks.

Three nuclear energy stocks have fallen significantly from their highs due to market headwinds. NuScale and Oklo, which develop innovative small modular reactors, have plummeted 86% and 79% respectively but lack commercial deployment and trade at extremely high valuations. BWX Technologies, a more established and profitable nuclear supplier with defense contracts, has only pulled back 40% and offers a more balanced opportunity in the resurgent nuclear market.

Cameco's stock has fallen from $134 to $85 after initial investor enthusiasm for nuclear power waned. However, the article argues this presents an opportunity, as nuclear power is experiencing a genuine renaissance driven by surging electricity demand from AI and electric vehicles. With uranium supply expected to fall short of demand in the early 2030s and Cameco owning half of Westinghouse, the company is well-positioned to benefit from the nuclear comeback.

BWX Technologies is positioned to outperform nuclear peers Oklo and NuScale through 2030 due to its established $3.2 billion revenue base and decades of nuclear manufacturing experience. While Oklo and NuScale are still commercializing reactor technologies, BWXT generates revenue from U.S. Navy contracts, TRISO fuel production, medical isotopes, and is developing advanced reactors and microreactors. The company raised its 2026 revenue guidance to $3.8 billion with 19% growth expected.